Abstract

Cirrhosis is a chronic, diffuse disease process characterized by fibrosis and remodeling of the organ's normal architectonics into regenerative nodules. It is also one of the risk factors for cancers of the organ. One of the most common is hepatocellular carcinoma (HCC). The etiologic agent of HCC, which usually also causes cirrhosis, can be determined in more than 90% of patients. The annual risk of developing HCC ranges from 1% to 8%. It is estimated that about 1/3 of cirrhotic patients will develop HCC. By preventing cirrhosis and controlling its course, we reduce the risk of hepatocellular carcinoma [1].

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.